Your browser doesn't support javascript.
loading
Clinical data supporting a 2-dose schedule of MenB-FHbp, a bivalent meningococcal serogroup B vaccine, in adolescents and young adults.
Beeslaar, Johannes; Absalon, Judith; Balmer, Paul; Srivastava, Amit; Maansson, Roger; York, Laura J; Perez, John L.
  • Beeslaar J; Pfizer Vaccine Clinical Research and Development, Hurley, UK. Electronic address: Johannes.Beeslaar@pfizer.com.
  • Absalon J; Pfizer Vaccine Clinical Research and Development, Pearl River, NY, USA.
  • Balmer P; Pfizer Vaccine Clinical Research and Development, Collegeville, PA, USA.
  • Srivastava A; Pfizer US Medical Affairs, Collegeville, PA, USA.
  • Maansson R; Pfizer Vaccine Clinical Research and Development, Collegeville, PA, USA.
  • York LJ; Pfizer Vaccines Medical Development, Scientific & Clinical Affairs, Collegeville, PA, USA.
  • Perez JL; Pfizer Vaccine Clinical Research and Development, Collegeville, PA, USA.
Vaccine ; 36(28): 4004-4013, 2018 06 27.
Article en En | MEDLINE | ID: mdl-29861182
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Proteínas Bacterianas / Esquemas de Inmunización / Vacunas Meningococicas / Neisseria meningitidis Serogrupo B / Meningitis Meningocócica / Antígenos Bacterianos Límite: Adolescent / Adult / Humans País como asunto: America do norte / Oceania Idioma: En Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Proteínas Bacterianas / Esquemas de Inmunización / Vacunas Meningococicas / Neisseria meningitidis Serogrupo B / Meningitis Meningocócica / Antígenos Bacterianos Límite: Adolescent / Adult / Humans País como asunto: America do norte / Oceania Idioma: En Año: 2018 Tipo del documento: Article